Prognostic significance of vascular invasion and cell-proliferation activity in widely invasive follicular carcinoma of the thyroid.
暂无分享,去创建一个
A. Miyauchi | Yasuhiro Ito | M. Kihara | T. Higashiyama | A. Miya | M. Fujishima | N. Onoda | H. Masuoka | M. Hirokawa
[1] Yasuhiro Ito,et al. The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer. , 2020, Endocrine journal.
[2] R. Lloyd,et al. WHO classification of tumours of endocrine organs , 2017 .
[3] M. Hirokawa,et al. Prognostic impact of Ki-67 labeling index in minimally invasive follicular thyroid carcinoma. , 2016, Endocrine journal.
[4] I. Reccia,et al. Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors , 2015, World Journal of Surgical Oncology.
[5] C. Lombardi,et al. Actual Incidence and Clinical Behaviour of Follicular Thyroid Carcinoma: An Institutional Experience , 2014, TheScientificWorldJournal.
[6] T. Uruno,et al. Does Hürthle Cell Carcinoma of the Thyroid Have a Poorer Prognosis than Ordinary Follicular Thyroid Carcinoma? , 2013, Annals of Surgical Oncology.
[7] T. Uruno,et al. Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. , 2011, Thyroid : official journal of the American Thyroid Association.
[8] M. Hirokawa,et al. Prognostic Significance of Ki-67 Labeling Index in Papillary Thyroid Carcinoma , 2010, World Journal of Surgery.
[9] M. Hirokawa,et al. Prognosis and Prognostic Factors of Follicular Carcinoma in Japan: Importance of Postoperative Pathological Examination , 2007, World Journal of Surgery.
[10] N. Ordóñez,et al. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid , 2003, Cancer.
[11] R. Golouh,et al. Prognostic factors in follicular carcinoma of the thyroid--a multivariate survival analysis. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[12] I. Fleming,et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995 , 1998, Cancer.
[13] M. Silverman,et al. Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy. , 1998, Surgery.
[14] M. Hirokawa,et al. Prognostic significance of patient age in minimally and widely invasive follicular thyroid carcinoma: investigation of three age groups. , 2014, Endocrine journal.
[15] M. Hirokawa,et al. Distant metastasis at diagnosis and large tumor size are significant prognostic factors of widely invasive follicular thyroid carcinoma. , 2013, Endocrine journal.
[16] M. Hirokawa,et al. Prognostic factors of minimally invasive follicular thyroid carcinoma: extensive vascular invasion significantly affects patient prognosis. , 2013, Endocrine journal.